Highlights Organogenesis Holdings Inc.

Equities

ORGO

US68621F1021

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-28 EDT			5-day change	1st Jan Change
2.8 ^USD	+6.06%		+12.00%	-31.54%

06-28	Lake Street Starts Organogenesis Holdings With Buy Rating, $5 Price Target	MT
05-13	Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup	05-10	DJ
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q1 Revenue $110M, vs. Street Est of $101.1M	05-09	MT
Organogenesis Holdings Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2024	05-09	CI
Organogenesis Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis	05-02	CI
Organogenesis Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q4 Revenue $99.7M, vs. Street Est of $109.1M	02-29	MT
Organogenesis Holdings Inc. Provides Earnings Guidance for the First Quarter and for the Year Ending December 31, 2024	02-29	CI
Organogenesis Holdings Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-29	CI
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q3 Revenue $108.5M, vs. Street Est of $111.4M	11-09	MT
Organogenesis Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
Organogenesis Holdings Inc. Provides Earnings Guidance for the Year Ending December 31, 2023	11-09	CI
Advanced Medical issues profit warning following royalty issues	23-09-04	AN
Advanced Medical Solutions Group Updates FY23 Guidance	23-09-04	MT
Organogenesis Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q2 Revenue $117.3M, vs. Street Est of $115.1M	23-08-09	MT
Organogenesis Holdings Inc. Withdraws Earnings Guidance for the the 2023	23-08-09	CI
Organogenesis Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Reports Q1 Revenue $107.6M	23-05-10	MT
Organogenesis Holdings Inc. Provides Earnings Guidance for the Fiscal Year 2023	23-05-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Organogenesis Holdings Inc.

Equities

ORGO

US68621F1021

Highlights

Filters